Search research articles
Contact Us
Filters
Showing results (51-60 of 56) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 56 results.
Journal of Affective Disorders
|
July 14, 1999
A Canadian multicenter, double-blind study of paroxetine and fluoxetine in major depressive disorder
G Chouinard, B Saxena, M C Bélanger, et al.
Clinical Neuropharmacology
|
January 1, 1993
Brofaromine in depression: a Canadian multicenter placebo trial and a review of standard drug comparative studies
G Chouinard, B M Saxena, N P Nair, et al.
Journal of Affective Disorders
|
October 1, 1994
A Canadian multicentre placebo-controlled study of a fixed dose of brofaromine, a reversible selective MAO-A inhibitor, in the treatment of major depression
G Chouinard, B M Saxena, N P Nair, et al.
Clinical Neuropharmacology
|
January 1, 1992
Efficacy and safety of brofaromine in depression: a Canadian multicenter placebo controlled trial and a review of comparative controlled studies
G Chouinard, B M Saxena, N P Nair, et al.
Journal of Clinical Psychopharmacology
|
August 5, 1998
A Canadian multicenter study of three fixed doses of controlled-release ipsapirone in outpatients with moderate to severe major depression
Y D Lapierre, P Silverstone, R T Reesal, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
March 1, 1996
ECNP position paper on social phobia proceedings from an ECNP workshop in Jerusalem, October 1994
S A Montgomery, D Bakish, R Buller, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 56) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 56 results.
Journal of Affective Disorders
|
July 14, 1999
A Canadian multicenter, double-blind study of paroxetine and fluoxetine in major depressive disorder
G Chouinard, B Saxena, M C Bélanger, et al.
Clinical Neuropharmacology
|
January 1, 1993
Brofaromine in depression: a Canadian multicenter placebo trial and a review of standard drug comparative studies
G Chouinard, B M Saxena, N P Nair, et al.
Journal of Affective Disorders
|
October 1, 1994
A Canadian multicentre placebo-controlled study of a fixed dose of brofaromine, a reversible selective MAO-A inhibitor, in the treatment of major depression
G Chouinard, B M Saxena, N P Nair, et al.
Clinical Neuropharmacology
|
January 1, 1992
Efficacy and safety of brofaromine in depression: a Canadian multicenter placebo controlled trial and a review of comparative controlled studies
G Chouinard, B M Saxena, N P Nair, et al.
Journal of Clinical Psychopharmacology
|
August 5, 1998
A Canadian multicenter study of three fixed doses of controlled-release ipsapirone in outpatients with moderate to severe major depression
Y D Lapierre, P Silverstone, R T Reesal, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
March 1, 1996
ECNP position paper on social phobia proceedings from an ECNP workshop in Jerusalem, October 1994
S A Montgomery, D Bakish, R Buller, et al.
Page
of 6